Senior insider sale
Chief Medical Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.26M
208.08K shares
What this filing means
TANIMOTO SARINA plans to sell 208.08K shares of ARS PHARMACEUTICALS, INC. valued at approximately $1.26M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/1/2026ACC: 0001950047-26-008961
Officer10% Owner· Chief Medical Officer
Since Nov 2022
208.08K
Shares to sell
$1.26M
Approx. market value
45.39K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/1/2026
45.39KTotal acquired45.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Stock Option Exercise Cash | 45.39K | — |
| Total | 45.39K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
63.29K
Market value
$368.1K
8/31/2026
—Completed
Units to sell
25K
Market value
$148.0K
8/20/2026
—Completed
Units to sell
25K
Market value
$161.2K
8/19/2026
—Completed
Units to sell
49.40K
Market value
$311.2K
8/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
45.39K
Market value
$272.8K
9/1/2026
Total
Units
208.08K
Value
$1.26M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/31/2026 | 63.29K | $368.1K | — | Completed |
8/20/2026 | 25K | $148.0K | — | Completed |
8/19/2026 | 25K | $161.2K | — | Completed |
8/18/2026 | 49.40K | $311.2K | — | Completed |
| Planned — Approximate Date | ||||
9/1/2026 | 45.39K | $272.8K | NASDAQ | Planned |
| Total | 208.08K | $1.26M | ||